Lupus anticoagulant in human immunodeficiency virus -infected patients on highly active antiretroviral therapy | Zendy

Edeghonghon Olayemi | Zendy; OA Awodu | Zendy; GodwinN Bazuaye | Zendy; AbelN Onunu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lupus anticoagulant in human immunodeficiency virus -infected patients on highly active antiretroviral therapy

Author(s) -

Edeghonghon Olayemi,

OA Awodu,

GodwinN Bazuaye,

AbelN Onunu

Publication year - 2010

Publication title -

indian journal of pathology and microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.217

H-Index - 31

eISSN - 0974-5130

pISSN - 0377-4929

DOI - 10.4103/0377-4929.59182

Subject(s) - antiretroviral therapy , medicine , human immunodeficiency virus (hiv) , lupus anticoagulant , virology , immunology , viral load , antibody

Lupus anticoagulant (LA) is a heterogeneous group of antibodies that causes a variety of clinical and laboratory effects; has been described in infections such as human immunodeficiency virus. LA has not been previously described in Nigerians with human immunodeficiency virus infection on highly active antiretroviral therapy (HAART).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research